LEVOSIMENDAN

UNII:	C6T4514L4E
Formula:	C₁₄H₁₂N₆O
Preferred Substance Name:	LEVOSIMENDAN
InChIKey:	WHXMKTBCFHIYNQ-SECBINFHSA-N

141505-33-1
(-)-OR-1259
(R)-((4-(1,4,5,6-TETRAHYDRO-4-METHYL-6-OXO-3-PYRIDAZINYL)PHENYL)HYDRAZONO) PROPANEDINTRILE
(R)-SIMENDAN
2-(2-(4-((4R)-1,4,5,6-TETRAHYDRO-4-METHYL-6-OXO-3-PYRIDAZINYL)PHENYL)HYDRAZINYLIDENE)PROPANEDINITRILE
LEVOSIMENDAN [INN]
LEVOSIMENDAN [MART.]
LEVOSIMENDAN [MI]
LEVOSIMENDAN [USAN]
LEVOSIMENDAN [WHO-DD]
MESOXALONITRILE (P-((R)-1,4,5,6-TETRAHYDRO-4-METHYL-6-OXO-PYRIDAZINYL)PHENYL)HYDRAZONE
NSC-759644
OR1259
OR-1259
PROPANEDINITRILE, ((4-(1,4,5,6-TETRAHYDRO-4-METHYL-6-OXO-3-PYRIDAZINYL)PHENYL)HYDRAZONO)-, (R)-
PROPANEDINITRILE, 2-(2-(4-((4R)-1,4,5,6-TETRAHYDRO-4-METHYL-6-OXO-3-PYRIDAZINYL)PHENYL)HYDRAZINYLIDENE)-
SIMDAX
SIMENDAN, (R)-

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LEVOSIMENDAN

Synonyms and Mappings

Resources